Last Price
0.81
Today's Change
-0.097 (10.69%)
Day's Change
0.77 - 0.924
Trading Volume
229,562
Profile
PRFX
Exchange: NASDAQ Capital Market NASDAQ Capital Market
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Mr. Ilan Hadar M.B.A. Mr. Ilan Hadar M.B.A.
Full Time Employees: 7 7
IPO Date: 2020-09-01 2020-09-01
CIK: 0001801834 0001801834
ISIN: IL0011651580 IL0011651580
CUSIP: M77798102 M77798102
Beta: 0.57 0.57
Last Dividend: 0.00 0.00
Dcf Diff: -4.03 -4.03
Dcf: 6.07 6.07
Description
PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company is currently conducting two Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. PainReform Ltd. was incorporated in 2007 and is based in Tel Aviv, Israel.
Address
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
12
Apps
Top Articles
1
CryptoNews
2
CEO Morning Brief
US Producer Prices Pick Up Slightly After Downward Revisions
3
4
CEO Morning Brief
5
CEO Morning Brief
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
